3D-printed drugs market, valued at USD 361.28 billion in 2024, is projected to grow at a CAGR of 8.07% from 2025 to 2032, reaching approximately USD 390.44 billion, driven by rising demand for personalized medicine, cost-efficient production, and novel controlled-release formulations.  To delve deeper into this research, kindly explore the following...